Hunan Fangsheng Pharm Co Ltd (603998) - Total Liabilities
Based on the latest financial reports, Hunan Fangsheng Pharm Co Ltd (603998) has total liabilities worth CN¥1.22 Billion CNY (≈ $179.02 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 603998 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Hunan Fangsheng Pharm Co Ltd - Total Liabilities Trend (2011–2025)
This chart illustrates how Hunan Fangsheng Pharm Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Hunan Fangsheng Pharm Co Ltd asset portfolio.
Hunan Fangsheng Pharm Co Ltd Competitors by Total Liabilities
The table below lists competitors of Hunan Fangsheng Pharm Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
LiJiang YuLong Tourism Co Ltd
SHE:002033
|
China | CN¥337.82 Million |
|
Hanwha Investment&Securities Co Ltd
KO:003530
|
Korea | ₩19.36 Trillion |
|
Kvutzat Acro Ltd.
TA:ACRO
|
Israel | ILA4.96 Billion |
|
Zhejiang Yankon Group Co Ltd
SHG:600261
|
China | CN¥1.65 Billion |
|
Chahua Modern Housewares Co Ltd
SHG:603615
|
China | CN¥631.90 Million |
|
CHINA VANKE CO.LTD H YC 1
F:18V
|
Germany | €769.34 Billion |
|
Hemnet Group AB
ST:HEM
|
Sweden | Skr1.14 Billion |
|
Udemy Inc
NASDAQ:UDMY
|
USA | $407.24 Million |
Liability Composition Analysis (2011–2025)
This chart breaks down Hunan Fangsheng Pharm Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 603998 net asset quality score to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.95 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.69 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.40 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Hunan Fangsheng Pharm Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Hunan Fangsheng Pharm Co Ltd (2011–2025)
The table below shows the annual total liabilities of Hunan Fangsheng Pharm Co Ltd from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥1.25 Billion ≈ $183.35 Million |
-18.20% |
| 2024-12-31 | CN¥1.53 Billion ≈ $224.14 Million |
+2.64% |
| 2023-12-31 | CN¥1.49 Billion ≈ $218.36 Million |
+5.52% |
| 2022-12-31 | CN¥1.41 Billion ≈ $206.94 Million |
+0.95% |
| 2021-12-31 | CN¥1.40 Billion ≈ $204.99 Million |
+43.37% |
| 2020-12-31 | CN¥977.05 Million ≈ $142.97 Million |
+23.29% |
| 2019-12-31 | CN¥792.51 Million ≈ $115.97 Million |
+49.58% |
| 2018-12-31 | CN¥529.81 Million ≈ $77.53 Million |
+57.97% |
| 2017-12-31 | CN¥335.39 Million ≈ $49.08 Million |
+15.13% |
| 2016-12-31 | CN¥291.31 Million ≈ $42.63 Million |
+115.88% |
| 2015-12-31 | CN¥134.94 Million ≈ $19.75 Million |
+56.03% |
| 2014-12-31 | CN¥86.48 Million ≈ $12.66 Million |
+8.79% |
| 2013-12-31 | CN¥79.50 Million ≈ $11.63 Million |
+39.51% |
| 2012-12-31 | CN¥56.98 Million ≈ $8.34 Million |
-17.28% |
| 2011-12-31 | CN¥68.89 Million ≈ $10.08 Million |
-- |
About Hunan Fangsheng Pharm Co Ltd
Hunan Fangsheng Pharmaceutical Co., Ltd. engages in research, develops, produces, and sells traditional Chinese medicine industry and chemical pharmaceutical products in China. The company offers pharmaceutical manufacturing; and provides cardiovascular and cerebrovascular drugs, skeletal muscle system drugs, orthopedic drugs, respiratory drugs, pediatric drugs, neurological drugs, gynecological … Read more